Nyhetsrum - PILA PHARMA | beQuoted Nyheter

Pressmeddelanden

2026-04-21 08:50

REG

PILA PHARMA PUBLISHES ITS ANNUAL REPORT FOR 2025 PILA PHARMA AB (publ), (FN STO: PILA), ("PILA PHARMA" or the "Company"), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition, announces that its A...

2026-04-16 14:15

REG MAR

PILA PHARMA: UPDATE TO PRECLINICAL RAT OBESITY STUDIES - LOW EXPOSURE OF XEN-D0501 COULD EXPLAIN LACK OF EFFECT ON BODYWEIGHT PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company"), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition, today announces that drug exposure in...

2026-04-16 08:40

REG

KALLELSE TILL ÅRSSTÄMMA I PILA PHARMA AB Aktieägarna i PILA PHARMA AB (publ), org.nr 556966-4831, ("PILA PHARMA" eller "Bolaget") kallas härmed till årsstämma tisdagen den 19 maj 2026, kl. 15.00 i Bolagets lokaler på No...

2026-03-19 17:00

PILA PHARMA CLARIFIES: DECISION TO POSTPONE THE ANNUAL REPORT TO AWAIT CONCLUSION ON PRECLINICAL OBESITY STUDIES PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") yesterday announced that the publication of the annual report for the 2025 fiscal year and the date for the annual general...

2026-03-18 18:15

REG

PILA PHARMA POSTPONES THE PUBLICATION OF THE ANNUAL REPORT AND THE ANNUAL GENERAL MEETING PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") announces that the publication of the annual report for the 2025 fiscal year will be postponed. The annual report is at an...

2026-03-05 16:15

PILA PHARMA: TO PARTICIPATE IN PHARMA PARTNERSHIP CONFERENCE BIO EUROPE SPRING IN LISBON, MARCH 23-25 PILA PHARMA AB (publ) (FN STO: PILA) ("PILA" or the "Company"), an innovative biotech company developing a novel oral drug based on TRPV1 inhibition, today shares its participati...

Visa fler pressmeddelanden